Tejnaksh Healthcare Limited stocks rally in the market as the company has launched new product Andro-Sim.
As per the filing, the product Andro Sim is a silicon model used by doctors to educate patients and doctors as to examine a patient, treat patients with intracavernosal injections, Intraurethral instillations, Practice penile implant surgeries, Urethral dilatation etc. It is the first of its kind simulator ever made globally.
This Product is part of the simulator series launched and promoted by Tejnaksh Healthcare Itd.
This simulator will help the Urologist and patient to understand treatment of infertility and andrology more efficiently, the company said.
At around 10:27 AM, Tejnaksh Healthcare was trading at Rs115.90 per share higher by 4.09% as against previous closing of Rs111.35 per share on the BSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
